Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)- 5-trifluoromethyl-phenyl]-3-(4-pyridin-3yl-pyrimidin-2-ylamino)-benzamide

Details for Australian Patent Application No. 2011202047 (hide)

Owner Novartis AG

Inventors Brozio, Jorg; Sutton, Paul Allen; Manley, Paul W.; Shieh, Wen-Chung; Wu, Raeann; Monnier, Stephanie; Karpinski, Piotr H.

Agent Davies Collison Cave

Pub. Number AU-A-2011202047

Parent 2006276204

Filing date 4 May 2011

Wipo publication date 26 May 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 May 2011 Complete Application Filed

26 May 2011 Application Open to Public Inspection

  Published as AU-A-2011202047

29 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202048-An improved weeding tool

2011202046-Sprinkler Device